WO2006087717A3 - Therapie exercant des effets non immediats - Google Patents

Therapie exercant des effets non immediats Download PDF

Info

Publication number
WO2006087717A3
WO2006087717A3 PCT/IL2006/000204 IL2006000204W WO2006087717A3 WO 2006087717 A3 WO2006087717 A3 WO 2006087717A3 IL 2006000204 W IL2006000204 W IL 2006000204W WO 2006087717 A3 WO2006087717 A3 WO 2006087717A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapy
immediate effects
patient
metabolic condition
target
Prior art date
Application number
PCT/IL2006/000204
Other languages
English (en)
Other versions
WO2006087717A2 (fr
Inventor
Benny Rousso
Tamar Harel
Original Assignee
Metacure N V
Benny Rousso
Tamar Harel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2005/000316 external-priority patent/WO2005087310A2/fr
Priority claimed from PCT/US2005/044557 external-priority patent/WO2006073671A1/fr
Priority to EP06711186.4A priority Critical patent/EP1868679B1/fr
Priority to US11/884,389 priority patent/US9101765B2/en
Application filed by Metacure N V, Benny Rousso, Tamar Harel filed Critical Metacure N V
Priority to EP06759102.4A priority patent/EP1898991B1/fr
Priority to US11/919,491 priority patent/US8548583B2/en
Priority to PCT/US2006/017281 priority patent/WO2006119467A2/fr
Publication of WO2006087717A2 publication Critical patent/WO2006087717A2/fr
Publication of WO2006087717A3 publication Critical patent/WO2006087717A3/fr
Priority to US11/802,685 priority patent/US8352031B2/en
Priority to US13/970,647 priority patent/US8977353B2/en
Priority to US14/641,480 priority patent/US9440080B2/en
Priority to US14/821,848 priority patent/US9821158B2/en
Priority to US15/249,506 priority patent/US10352948B2/en
Priority to US16/232,088 priority patent/US20190137513A1/en
Priority to US17/524,015 priority patent/US11779768B2/en
Priority to US18/377,857 priority patent/US20240042214A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4519—Muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37205—Microstimulators, e.g. implantable through a cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37288—Communication to several implantable medical devices within one patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Emergency Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procédé servant à traiter un état métabolique chez un patient qui consiste à : déterminer une cible thérapeutique à effet non immédiat associée au traitement de cet état métabolique et à appliquer un champ électrique à la cavité abdominale du patient, de façon à au moins approcher ladite cible.
PCT/IL2006/000204 1999-03-05 2006-02-16 Therapie exercant des effets non immediats WO2006087717A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
EP06711186.4A EP1868679B1 (fr) 2005-02-17 2006-02-16 Therapie exercant des effets non immediats
US11/884,389 US9101765B2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
EP06759102.4A EP1898991B1 (fr) 2005-05-04 2006-05-04 Modification d'activite de proteine
US11/919,491 US8548583B2 (en) 2004-03-10 2006-05-04 Protein activity modification
PCT/US2006/017281 WO2006119467A2 (fr) 2005-05-04 2006-05-04 Modification d'activite de proteine
US11/802,685 US8352031B2 (en) 2004-03-10 2007-05-24 Protein activity modification
US13/970,647 US8977353B2 (en) 2004-03-10 2013-08-20 Protein activity modification
US14/641,480 US9440080B2 (en) 2004-03-10 2015-03-09 Protein activity modification
US14/821,848 US9821158B2 (en) 2005-02-17 2015-08-10 Non-immediate effects of therapy
US15/249,506 US10352948B2 (en) 2004-03-10 2016-08-29 Protein activity modification
US16/232,088 US20190137513A1 (en) 2004-03-10 2018-12-26 Protein activity modification
US17/524,015 US11779768B2 (en) 2004-03-10 2021-11-11 Protein activity modification
US18/377,857 US20240042214A1 (en) 2004-12-09 2023-10-09 Protein activity modification

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US65405605P 2005-02-17 2005-02-17
US60/654,056 2005-02-17
ILPCT/IL2005/000316 2005-03-18
PCT/IL2005/000316 WO2005087310A2 (fr) 2004-03-18 2005-03-18 Procedes et appareils gastro-intestinaux destines a etre utilises dans le traitement des troubles et le controle de glycemie
US67776105P 2005-05-04 2005-05-04
US60/677,761 2005-05-04
US71942105P 2005-09-22 2005-09-22
US71951705P 2005-09-22 2005-09-22
US60/719,421 2005-09-22
US60/719,517 2005-09-22
USPCT/US2005/044557 2005-12-09
PCT/US2005/044557 WO2006073671A1 (fr) 2004-12-09 2005-12-09 Modification de l'activite proteique

Related Parent Applications (5)

Application Number Title Priority Date Filing Date
US10/497,126 Continuation-In-Part US20070060812A1 (en) 2001-11-29 2002-10-24 Sensing of pancreatic electrical activity
PCT/IL2002/000856 Continuation-In-Part WO2003045493A2 (fr) 1999-03-05 2002-10-24 Detection de l'activite electrique pancreatique
PCT/IL2004/000797 Continuation-In-Part WO2005023081A2 (fr) 1999-03-05 2004-09-05 Controle du niveau de glucose dans le sang
PCT/IL2005/000316 Continuation-In-Part WO2005087310A2 (fr) 1999-03-05 2005-03-18 Procedes et appareils gastro-intestinaux destines a etre utilises dans le traitement des troubles et le controle de glycemie
PCT/US2005/044557 Continuation-In-Part WO2006073671A1 (fr) 1999-03-05 2005-12-09 Modification de l'activite proteique

Related Child Applications (6)

Application Number Title Priority Date Filing Date
US11/884,389 A-371-Of-International US9101765B2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
US11/919,491 Continuation US8548583B2 (en) 2004-03-10 2006-05-04 Protein activity modification
PCT/US2006/017281 Continuation WO2006119467A2 (fr) 2004-03-10 2006-05-04 Modification d'activite de proteine
PCT/US2006/017281 Continuation-In-Part WO2006119467A2 (fr) 2004-03-10 2006-05-04 Modification d'activite de proteine
US11/802,685 Continuation US8352031B2 (en) 2004-03-10 2007-05-24 Protein activity modification
US14/821,848 Division US9821158B2 (en) 2005-02-17 2015-08-10 Non-immediate effects of therapy

Publications (2)

Publication Number Publication Date
WO2006087717A2 WO2006087717A2 (fr) 2006-08-24
WO2006087717A3 true WO2006087717A3 (fr) 2006-12-14

Family

ID=36916849

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/000204 WO2006087717A2 (fr) 1999-03-05 2006-02-16 Therapie exercant des effets non immediats

Country Status (2)

Country Link
EP (1) EP1868679B1 (fr)
WO (1) WO2006087717A2 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US8958872B2 (en) 1996-01-08 2015-02-17 Impulse Dynamics, N.V. Electrical muscle controller
US8977353B2 (en) 2004-03-10 2015-03-10 Impulse Dynamics Nv Protein activity modification
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US9265930B2 (en) 1997-07-16 2016-02-23 Metacure Limited Methods and devices for modifying vascular parameters
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
CA2594673A1 (fr) 2004-12-09 2006-07-13 Impulse Dynamics Nv Modification de l'activite proteique
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
EP1861160B1 (fr) 2005-03-24 2011-11-16 Metacure Limited Conducteurs sans fil pour applications aux tractus gastro-intestinal
US9233075B2 (en) 2005-08-09 2016-01-12 Metacure Limited Satiety
WO2008139463A2 (fr) 2007-05-09 2008-11-20 Metacure Ltd. Analyse et régulation d'une absorption de nourriture
WO2012083259A2 (fr) 2010-12-17 2012-06-21 Neural Diabetes Foundation, Inc. Méthode, système et appareil pour réguler la fonction des cellules bêta pancréatiques et améliorer l'homéostasie du glucose et la production d'insuline
WO2016028608A1 (fr) 2014-08-17 2016-02-25 Nine Continents Medical, Inc. Système de neurostimulateur implantable miniature pour le nerf sciatique et ses ramifications
WO2023235443A1 (fr) * 2022-06-01 2023-12-07 Dexcom, Inc. Systèmes et procédés de détection pour diagnostiquer une maladie rénale

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6895278B1 (en) * 1999-04-14 2005-05-17 Transneuronix, Inc. Gastric stimulator apparatus and method for use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1868679A4 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8958872B2 (en) 1996-01-08 2015-02-17 Impulse Dynamics, N.V. Electrical muscle controller
US9186514B2 (en) 1996-01-08 2015-11-17 Impulse Dynamics Nv Electrical muscle controller
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9265930B2 (en) 1997-07-16 2016-02-23 Metacure Limited Methods and devices for modifying vascular parameters
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8977353B2 (en) 2004-03-10 2015-03-10 Impulse Dynamics Nv Protein activity modification
US9440080B2 (en) 2004-03-10 2016-09-13 Impulse Dynamics Nv Protein activity modification
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy

Also Published As

Publication number Publication date
WO2006087717A2 (fr) 2006-08-24
EP1868679A2 (fr) 2007-12-26
EP1868679B1 (fr) 2017-05-03
EP1868679A4 (fr) 2012-10-24

Similar Documents

Publication Publication Date Title
WO2006087717A3 (fr) Therapie exercant des effets non immediats
EP3150204A3 (fr) Traitement du diabète chez des patients dont la régulation glycémique est insuffisante malgré une thérapie par un médicament antidiabétique oral ou non oral
WO2006099610A3 (fr) Methodes d'identification de cibles therapeutiques pour le traitement de l'atrophie vulvovaginale
WO2008127373A3 (fr) Procédés et dispositifs de traitement de tissus
WO2009051706A3 (fr) Composés peptidiques pour le traitement de l'obésité et de la résistance à l'insuline
WO2006113802A3 (fr) Dispositif pour l'administration de stimulation par electrodes des muscles dorsaux et abdominaux
WO2006119467A3 (fr) Modification d'activite de proteine
WO2008016922A3 (fr) Fig. 9traitement péri-capsulaire de fibroïdes
WO2004064728A3 (fr) Composes de tetracycline possedant des activites therapeutiques ciblees
WO2006127007A3 (fr) Procedes d'utilisation de cellules derivees de tissus adipeux dans le traitement de maladies cardiovasculaires
WO2007089454A3 (fr) Procédés pour améliorer des traitements pour la peau
WO2005096990A3 (fr) Nouvelle modification de protheses medicales
EP2272453A4 (fr) Système thérapeutique, instrument thérapeutique et procédé de traitement énergétique de tissus vivants
WO2007128761A3 (fr) Utilisations d'inhibiteurs de l'enzyme dpp iv
AU2003231011A1 (en) Independent therapy programs in an implantable medical device
WO2006073671A8 (fr) Modification de l'activite proteique
WO2005123094A3 (fr) Composes renfermant du bore et procedes d'utilisation de ceux-ci
WO2007006012A3 (fr) Procedes pour limiter la quantite d'agents pathogenes presents dans des echantillons biologiques
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
WO2007028123A3 (fr) Pose d'implant cochleaire
WO2007064900A3 (fr) Traitement de lesions ou d'imperfections de tissus mammaliens cutanes ou proches de la peau ou dans ou pres d'autres surfaces anatomiques
WO2009079451A3 (fr) Compositions et procédés pour favoriser la guérison d'une plaie
WO2009031606A1 (fr) Agents thérapeutiques et prophylactiques pour l'arthrite
WO2007100728A3 (fr) Dérivés du mannose pour tuer des cellules tumorales
WO2010077339A3 (fr) Effecteurs de la β-arrestine, compositions en contenant et leurs procédés d'utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11802685

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 11884389

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2006711186

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006711186

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11802685

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006711186

Country of ref document: EP